{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:04:29Z","timestamp":1790798669253,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jtha.2026.07.012","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:05:35Z","timestamp":1784822735000},"page":"3679-3686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of fibrinogen \u03b3\u2019 with recurrent thrombosis: a nested case-control study"],"prefix":"10.1016","volume":"24","author":[{"given":"Nora","family":"Arvesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Else-Marie","family":"Bladbjerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3047-9924","authenticated-orcid":false,"given":"Nadja B\u00f8dker","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Berg-Beckhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moniek P.M.","family":"de Maat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren Paaske","family":"Johnsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Marie Bloch","family":"M\u00fcnster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.07.012_bib1","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/CIRCRESAHA.115.306841","article-title":"Global burden of thrombosis: epidemiologic aspects","volume":"118","author":"Wendelboe","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.jtha.2026.07.012_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CLEP.S4780","article-title":"Venous and arterial thrombosis: two aspects of the same disease?","volume":"1","author":"Prandoni","year":"2009","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jtha.2026.07.012_bib3","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3324\/haematol.2019.236901","article-title":"Fibrin(ogen) in human disease: both friend and foe","volume":"105","author":"Vilar","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2026.07.012_bib4","series-title":"Braunwald\u2019s heart disease: a textbook of cardiovascular medicine","first-page":"442","article-title":"Primary prevention of cardiovascular disease","author":"Mora","year":"2022"},{"key":"10.1016\/j.jtha.2026.07.012_bib5","series-title":"Braunwald\u2019s heart disease: a textbook of cardiovascular medicine","first-page":"1635","article-title":"Pulmonary embolism and deep vein thrombosis","author":"Goldhaber","year":"2022"},{"key":"10.1016\/j.jtha.2026.07.012_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002883","article-title":"Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: the Leiden thrombosis recurrence risk prediction model (L-TRRiP)","volume":"16","author":"Timp","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.jtha.2026.07.012_bib7","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1002\/ajh.23128","article-title":"Predicting the risk of venous thromboembolism recurrence","volume":"87","author":"Heit","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2026.07.012_bib8","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1111\/jth.14534","article-title":"Predicting the risk of recurrent venous thrombosis: what the future might bring","volume":"17","author":"Lijfering","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.07.012_bib9","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1016\/S0021-9258(19)44960-0","article-title":"Human fibrinogen heterogeneities. 3. Identification of chain variants","volume":"247","author":"Mosesson","year":"1972","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2026.07.012_bib10","doi-asserted-by":"crossref","first-page":"12826","DOI":"10.1016\/S0021-9258(18)90821-5","article-title":"Structure of the human gamma-fibrinogen gene. Alternate mRNA splicing near the 3' end of the gene produces gamma A and gamma B forms of gamma-fibrinogen","volume":"259","author":"Fornace","year":"1984","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2026.07.012_bib11","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1021\/bi00313a033","article-title":"Gamma and gamma\u2019 chains of human fibrinogen are produced by alternative mRNA processing","volume":"23","author":"Chung","year":"1984","journal-title":"Biochemistry"},{"key":"10.1016\/j.jtha.2026.07.012_bib12","doi-asserted-by":"crossref","first-page":"6146","DOI":"10.1021\/bi00524a036","article-title":"Carboxy-terminal amino acid sequence of a human fibrinogen gamma-chain variant (gamma')","volume":"20","author":"Wolfenstein-Todel","year":"1981","journal-title":"Biochemistry"},{"key":"10.1016\/j.jtha.2026.07.012_bib13","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1182\/blood-2009-05-217968","article-title":"The pleiotropic role of the fibrinogen gamma' chain in hemostasis","volume":"114","author":"Uitte de Willige","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.07.012_bib14","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1182\/blood-2002-10-3150","article-title":"Fibrinogen gamma-chain splice variant gamma' alters fibrin formation and structure","volume":"102","author":"Cooper","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.07.012_bib15","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1182\/blood-2005-01-0240","article-title":"Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains","volume":"106","author":"Siebenlist","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.07.012_bib16","doi-asserted-by":"crossref","first-page":"14251","DOI":"10.1074\/jbc.272.22.14251","article-title":"Resistance of gammaA\/gamma' fibrin clots to fibrinolysis","volume":"272","author":"Falls","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2026.07.012_bib17","doi-asserted-by":"crossref","first-page":"10448","DOI":"10.1021\/bi9606206","article-title":"Plasma factor XIII binds specifically to fibrinogen molecules containing gamma chains","volume":"35","author":"Siebenlist","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.jtha.2026.07.012_bib18","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1074\/jbc.M707710200","article-title":"Bivalent binding to gammaA\/gamma'-fibrin engages both exosites of thrombin and protects it from inhibition by the antithrombin-heparin complex","volume":"283","author":"Fredenburgh","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2026.07.012_bib19","first-page":"S35","article-title":"Plasma gamma'\/gamma fibrinogen ratio, a marker of arterial thrombotic activity: a new potential cardiovascular risk factor?","volume":"10","author":"Drouet","year":"1999","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jtha.2026.07.012_bib20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-0037-1613148","article-title":"Association of gammaA\/gamma' fibrinogen levels and coronary artery disease","volume":"88","author":"Lovely","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.07.012_bib21","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1538-7836.2007.02406.x","article-title":"Elevated plasma fibrinogen gamma' concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors","volume":"5","author":"Mannila","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.07.012_bib22","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1161\/STROKEAHA.107.495499","article-title":"Fibrinogen gamma' in ischemic stroke: a case-control study","volume":"39","author":"Cheung","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2026.07.012_bib23","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1182\/blood-2009-08-236240","article-title":"Elevated fibrinogen gamma' ratio is associated with cardiovascular diseases and acute phase reaction but not with clinical outcome","volume":"114","author":"Cheung","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.07.012_bib24","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1055\/s-0036-1572353","article-title":"The (patho)physiology of fibrinogen gamma'","volume":"42","author":"Macrae","year":"2016","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.07.012_bib25","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1111\/jth.12354","article-title":"Inhibition of thrombin-mediated factor V activation contributes to the anticoagulant activity of fibrinogen gamma'","volume":"11","author":"Omarova","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.07.012_bib26","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1182\/blood-2014-02-554055","article-title":"Fibrinogen gamma' increases the sensitivity to activated protein C in normal and factor V Leiden plasma","volume":"124","author":"Omarova","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.07.012_bib27","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1365-2141.2007.06825.x","article-title":"Fibrinogen gamma' chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway","volume":"139","author":"Lovely","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.07.012_bib28","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1182\/blood-2005-05-2180","article-title":"Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels","volume":"106","author":"Uitte de Willige","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.07.012_bib29","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jtha.2026.07.012_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102319","article-title":"Validation of a fibrinogen gamma' enzyme-linked immunosorbent assay using a new monoclonal antibody: effects of bariatric surgery","volume":"8","author":"Pedersen","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.07.012_bib31","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/clinchem\/45.5.694","article-title":"Rapid detection of prothrombotic mutations of prothrombin (G20210A), factor V (G1691A), and methylenetetrahydrofolate reductase (C677T) by real-time fluorescence PCR with the LightCycler","volume":"45","author":"von Ahsen","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/j.jtha.2026.07.012_bib32","article-title":"Analysis of matched case-control studies","volume":"352","author":"Pearce","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2026.07.012_bib33","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000210061","article-title":"Clinical and biomarker determinants for recurrent stroke in patients with atrial fibrillation: a systematic review and meta-analysis","volume":"104","author":"Cheung","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.jtha.2026.07.012_bib34","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1056\/NEJMoa054444","article-title":"D-dimer testing to determine the duration of anticoagulation therapy","volume":"355","author":"Palareti","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.07.012_bib35","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3390\/jcm9051582","article-title":"Predicting the risk of recurrent venous thromboembolism: current challenges and future opportunities","volume":"9","author":"Stevens","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jtha.2026.07.012_bib36","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJM200008173430702","article-title":"High plasma levels of factor VIII and the risk of recurrent venous thromboembolism","volume":"343","author":"Kyrle","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.07.012_bib37","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1046\/j.1365-2141.2003.04795.x","article-title":"High plasma levels of factor VIII and risk of recurrence of venous thromboembolism","volume":"124","author":"Cristina","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.07.012_bib38","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/jth.13113","article-title":"Predictive value of factor VIII levels for recurrent venous thrombosis: results from the MEGA follow-up study","volume":"13","author":"Timp","year":"2015","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362600468X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362600468X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:46:03Z","timestamp":1790797563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153878362600468X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S153878362600468X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.07.012","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of fibrinogen \u03b3\u2019 with recurrent thrombosis: a nested case-control study","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}